Flavopiridol, Fludarabine, and Rituximab in Mantle Cell Lymphoma and Indolent B-Cell Lymphoproliferative Disorders

PURPOSE: Flavopiridol downmodulates antiapoptotic proteins associated with resistance to fludarabine and rituximab and is effective against p53-mutated chronic lymphocytic leukemia (CLL). We conducted a phase I study of flavopiridol, fludarabine, and rituximab (FFR) in patients with mantle-cell lymp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lin, Thomas S., Blum, Kristie A., Fischer, Diane Beth, Mitchell, Sarah M., Ruppert, Amy S., Porcu, Pierluigi, Kraut, Eric H., Baiocchi, Robert A., Moran, Mollie E., Johnson, Amy J., Schaaf, Larry J., Grever, Michael R., Byrd, John C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2815704/
https://ncbi.nlm.nih.gov/pubmed/20008633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.24.1570
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados